» Articles » PMID: 34947839

The Concept of "Cancer Stem Cells" in the Context of Classic Carcinogenesis Hypotheses and Experimental Findings

Overview
Journal Life (Basel)
Specialty Biology
Date 2021 Dec 24
PMID 34947839
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

In this , the operational definition of or includes the ability of certain cells, found in a heterogeneous mixture of cells within a tumor, which are able to sustain growth of that tumor. However, that concept of does not resolve the age-old controversy of two opposing hypotheses of the origin of the cancer, namely the hypothesis versus the or hypothesis. Moreover, this concept has to take into account classic experimental observations, techniques, and concepts, such as the multi-stage, multi-mechanism process of carcinogenesis; roles of mutagenic, cytotoxic and epigenetic mechanisms; the important differences between and in forming mutations; biomarkers of known characteristics of normal adult organ-specific stem cells and of cancer stem cells; and the characteristics of epigenetic mechanisms involved in the carcinogenic process. In addition, vague and misleading terms, such as have to be clarified in the context of current scientific facts. The ultimate integration of all of these historic factors to provide a current understanding of the origin and characteristics of a , which is required for a rational strategy for prevention and therapy for cancer, does not follow a linear path. Lastly, it will be speculated that there exists evidence of two distinct types of , one that has its origin in an organ-specific adult stem cell that is 'initiated' in the stem cell stage, expressing the Oct4A gene and not expressing any connexin gene or having functional gap junctional intercellular communication (GJIC). The other is derived from a stem cell that is initiated early after the Oct4A gene is suppressed and the connexin gene is expressed, which starts early differentiation, but it is blocked from terminal differentiation.

Citing Articles

A Comprehensive Review of Protein Biomarkers for Invasive Lung Cancer.

Mezentsev A, Durymanov M, Makarov V Curr Oncol. 2024; 31(9):4818-4854.

PMID: 39329988 PMC: 11431409. DOI: 10.3390/curroncol31090360.


Editorial for the Special Issue "Genetics and Genomics of Gastrointestinal Cancers: From Prevention to Treatment".

Marabelli M, Bertario L, Serrano D Genes (Basel). 2023; 14(9).

PMID: 37761961 PMC: 10530279. DOI: 10.3390/genes14091821.


Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance.

Maleki E, Bahrami A, Matin M Genes Dis. 2023; 11(1):189-204.

PMID: 37588236 PMC: 10425754. DOI: 10.1016/j.gendis.2022.11.025.


& Co. at the Stem of Cancer: Microbe-Cancer Stem Cell Interactions in Colorectal Carcinogenesis.

Pani G Cancers (Basel). 2023; 15(9).

PMID: 37174049 PMC: 10177588. DOI: 10.3390/cancers15092583.


Stemming Tumoral Growth: A Matter of Grotesque Organogenesis.

Merino M, Garcia-Sanz J Cells. 2023; 12(6).

PMID: 36980213 PMC: 10047265. DOI: 10.3390/cells12060872.


References
1.
Saraei P, Asadi I, Azam Kakar M, Moradi-Kor N . The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances. Cancer Manag Res. 2019; 11:3295-3313. PMC: 6497052. DOI: 10.2147/CMAR.S200059. View

2.
BERENBLUM I . A speculative review; the probable nature of promoting action and its significance in the understanding of the mechanism of carcinogenesis. Cancer Res. 1954; 14(7):471-7. View

3.
Trosko J . Challenge to the simple paradigm that 'carcinogens' are 'mutagens' and to the in vitro and in vivo assays used to test the paradigm. Mutat Res. 1997; 373(2):245-9. DOI: 10.1016/s0027-5107(96)00203-5. View

4.
Clemente-Perivan S, Gomez-Gomez Y, Leyva-Vazquez M, Lagunas-Martinez A, Organista-Nava J, Illades-Aguiar B . Role of Oct3/4 in Cervical Cancer Tumorigenesis. Front Oncol. 2020; 10:247. PMC: 7079573. DOI: 10.3389/fonc.2020.00247. View

5.
MARKERT C . Neoplasia: a disease of cell differentiation. Cancer Res. 1968; 28(9):1908-14. View